Skip to main content
ASNDSector not reported

Ascendis Pharma A/S - ADR (ASND) Insider Trading

In the last 90 days, 3 Ascendis Pharma A/S - ADR (ASND) insiders reported 1 open-market purchase totaling $492,654 and 2 sales totaling $872,905. The most recent open-market purchase was reported on Aug 14, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$492,654
Corporate buyers
1
Latest transaction
Sep 8, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 8, 2026Mads BodenhoffSVP & PAOSale3,000$270.19$810,570
Sep 2, 2026Lars HoltugDirectorSale236$264.13$62,335
Aug 14, 2026Jean Jacques BienaimeDirectorOpen Market Purchase2,000$246.33$492,654
Jun 2, 2026Scott Thomas SmithEVP & Chief Financial OfficerOpen Market Purchase100$219.00$21,900
May 29, 2026Jean Jacques BienaimeDirectorOpen Market Purchase500$223.12$111,562
May 29, 2026Scott Thomas SmithEVP & Chief Financial OfficerOpen Market Purchase250$223.32$55,830
May 26, 2026Jean Jacques BienaimeDirectorOpen Market Purchase400$237.80$95,121
May 11, 2026Flemming Steen JensenSee RemarksSale19,460$238.49$4,641,021

Common questions

ASND insider trading FAQ

Are ASND insiders buying or selling?
Over the last 90 days, ASND insiders were net sellers, reporting $492,654 of open-market purchases and $872,905 of sales.
When was the last ASND insider purchase?
The most recent open-market purchase of Ascendis Pharma A/S - ADR stock by an insider was reported on Aug 14, 2026, one of 1 purchase in the last 90 days.
Where does ASND insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Ascendis Pharma A/S - ADR officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.